The estimated Net Worth of Capital Ii Ventech is at least $2.2 Milion dollars as of 13 March 2017. Capital Ventech owns over 4,419 units of Scynexis Inc stock worth over $2,004,540 and over the last 11 years Capital sold SCYX stock worth over $194,867.
Capital has made over 5 trades of the Scynexis Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently Capital sold 4,419 units of SCYX stock worth $12,373 on 13 March 2017.
The largest trade Capital's ever made was buying 102,777 units of Scynexis Inc stock on 19 February 2015 worth over $616,662. On average, Capital trades about 38,639 units every 208 days since 2014. As of 13 March 2017 Capital still owns at least 1,431,814 units of Scynexis Inc stock.
You can see the complete history of Capital Ventech stock trades at the bottom of the page.
Capital's mailing address filed with the SEC is 47 AVENUE DE L'OPERA, , PARIS, I0, 75002.
Over the last 11 years, insiders at Scynexis Inc have traded over $4,708,140 worth of Scynexis Inc stock and bought 2,173,590 units worth $13,469,713 . The most active insiders traders include Advisors Llcperceptive Life..., Patrick Machado a Marco Taglietti. On average, Scynexis Inc executives and independent directors trade stock every 49 days with the average trade being worth of $64,694. The most recent stock trade was executed by Marco Taglietti on 26 April 2022, trading 75,000 units of SCYX stock currently worth $225,000.
scynexis, inc. is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. our scientists have extensive experience in the life sciences industry having, together and individually, been involved in the discovery and development of innovative medicines over a broad range of therapy areas. we are developing our lead product candidate, scy-078, a novel antifungal in phase 2, as a novel oral and intravenous drug for the treatment of serious and life-threatening invasive fungal infections in humans.
Scynexis Inc executives and other stock owners filed with the SEC include: